<- Go Home
Pardes Biosciences, Inc.
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to treat and prevent viral diseases. The company was incorporated in 2020 and is based in Carlsbad, California. As of August 31, 2023, Pardes Biosciences, Inc. operates as a subsidiary of MediPacific, Inc.
Market Cap
$131.2M
Volume
231.0K
Cash and Equivalents
$100.3M
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$3.67
52 Week Low
$0.75
Dividend
N/A
Price / Book Value
0.84
Price / Earnings
-1.69
Price / Tangible Book Value
0.84
Enterprise Value
-$22.0M
Enterprise Value / EBITDA
N/A
Operating Income
-$82.9M
Return on Equity
40.28%
Return on Assets
-26.49
Cash and Short Term Investments
$153.2M
Debt
N/A
Equity
$155.4M
Revenue
N/A
Unlevered FCF
-$51.1M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium